TITLE

Guidelines for the management of chronic kidney disease

AUTHOR(S)
Levin, Adeera; Hemmelgarn, Brenda; Culleton, Bruce; Tobe, Sheldon; McFarlane, Philip; Ruzicka, Marcel; Burns, Kevin; Manns, Braden; White, Colin; Madore, Francoise; Moist, Louise; Klarenbach, Scott; Barrett, Brendan; Foley, Robert; Jindal, Kailash; Senior, Peter; Pannu, Neesh; Shurraw, Sabin; Akbari, Ayub; Cohn, Adam
PUB. DATE
November 2008
SOURCE
CMAJ: Canadian Medical Association Journal;11/18/2008, Vol. 179 Issue 11, p1154
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses guidelines for chronic kidney disease management that were developed by the Canadian Society of Nephrology. The guidelines explains key aspects of the management of the disease to promote shared care for these patients by general practitioners and specialists. In particular, these guidelines are for the care of patients who are not undergoing dialysis. The authors offer recommendations from the guidelines on aspects of management of chronic kidney disease. These include strategies for treatment, targets for different abnormalities and frequency of follow-up based on the evidence available.
ACCESSION #
35167016

 

Related Articles

  • eGFR not accurate enough for QOF.  // Pulse;4/27/2006, Vol. 66 Issue 17, p2 

    The article reports on the inaccuracy of the diagnostic algorithm in the quality and outcomes framework, designed to help general practitioners to identify patients with chronic kidney disease (CKD), specifically in Great Britain. A study of the method has revealed that using the formula for...

  • How have GPs coped with CKD? Anekwe, Lilian // Pulse;5/31/2007, Vol. 67 Issue 21, p15 

    The article evaluates general practitioners' (GP) capacity to manage chronic kidney disease (CKD) as CKD is added to the quality and outcomes framework in Great Britain. Many GP are nervous at the prospect of having to learn a whole new disease. Inappropriate referrals are still proliferating...

  • Chronic Care Medicine: Physicians Say 'Help!'.  // Ascribe Newswire: Medicine;6/10/2004, p5 

    In a national survey of practicing family physicians, pediatricians, internists and surgeons, the majority reported that their training in chronic care medicine was too thin overall to meet the demands of their practices. Specifically, nearly two-thirds felt poorly trained in skills related to...

  • Calciphylaxis in pediatric end-stage renal disease. Imam, Abubakr A.; Mattoo, Tej K.; Kapur, Gaurav; Bloom, David A.; Valentini, Rudolph P. // Pediatric Nephrology;Dec2005, Vol. 20 Issue 12, p1776 

    Calciphylaxis is a rare, but life-threatening complication of end-stage renal disease (ESRD) that has been reported mostly in adult patients. The exact etiology is unknown, but the disease is commonly associated with a high calcium-phosphorus product and elevated levels of parathyroid hormone...

  • Big-head disease: Uremic leontiasis ossea. Kumar, S.; Thuraisingham, R.; Yaqoob, M. // Kidney International;May2006, Vol. 69 Issue 10, p1709 

    The article presents a nephrology image of the big-head disease, uremic leontiasis ossea. The patient is a 46-year-old woman with known epilepsy, on long-term phenobarbitone therapy and who developed end-stage renal failure. A photograph of her, showing bulging of malar bones and widening of...

  • Long-term effects of a new ketoacid-amino acid supplement in patients with chronic renal failure. Mitch, William E.; Abras, Elias; Walser, Mackenzie // Kidney International;Jul1982, Vol. 22 Issue 1, p48 

    Nine patients with severe chronic renal failure (mean glomerular filtration rate 4.8 ml/min; mean serum creatinine 11.3 mg/dl) who were previously on a protein-restricted diet were treated with a diet containing an average of 33 kcal/kg and 22.5 g/day of mixed quality protein, supplemented by a...

  • Chapter 16. Management of CKD.  // Clinical & Experimental Nephrology;Jun2009, Vol. 13 Issue 3, p226 

    The article explores issues related to the management of chronic kidney disease (CKD). The basic aim of CKD management is to block CKD or retard its progression to end-stage kidney disease (ESKD), which reduces the quality of life of CKD patients. Management of ESKD needs relatively costly renal...

  • Progression of kidney disease: Blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Anders, H. -J.; Ninichuk, V.; Schlöndorff, D. // Kidney International;Jan2006, Vol. 69 Issue 1, p29 

    Chronic kidney disease (CKD) is usually associated with interstitial leukocytic cell infiltrates, which may contribute to disease progression by production of proinflammatory, proapoptotic, and profibrotic mediators. Recruiting leukocytes into the kidney involves local expression of chemotactic...

  • Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure. Koziolek, Michael J.; Müller, Gerhard-Anton; Zapf, Antonia; Patschan, Daniel; Schmid, Holger; Cohen, Clemens D.; Koschnick, Stefan; Vasko, Radovan; Bramlage, Carsten; Strutz, Frank // Nephrology Dialysis Transplantation;Mar2010, Vol. 25 Issue 3, p684 

    Background. The chemokine/chemokine receptor pair CX3C-L/CX3C-R is suspected to play a role in renal fibrogenesis. The aim of this study was to investigate their function in an animal model of slowly progressive chronic renal failure.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics